chloroquine and inno-406

chloroquine has been researched along with inno-406 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, S; Ashihara, E; Hiraumi, Y; Kamitsuji, Y; Kawata, E; Kimura, S; Kuroda, J; Maekawa, T; Matsubara, H; Mizushima, Y; Nakahata, T; Tanaka, H; Toyokuni, S; Watanabe, K; Watanabe, M; Yoshikawa, T; Yui, Y	1

Other Studies

1 other study(ies) available for chloroquine and inno-406

Article	Year
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias. Cell death and differentiation, 2008, Volume: 15, Issue:11 Topics: Animals; Apoptosomes; Autophagy; Caspases; Cell Line, Tumor; Chloroquine; Cytoprotection; Disease Models, Animal; Enzyme Activation; Fusion Proteins, bcr-abl; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, SCID; Protein Kinase Inhibitors; Pyrimidines; Xenograft Model Antitumor Assays	2008

Article

Year

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias.

Cell death and differentiation, 2008, Volume: 15, Issue:11

Topics: Animals; Apoptosomes; Autophagy; Caspases; Cell Line, Tumor; Chloroquine; Cytoprotection; Disease Models, Animal; Enzyme Activation; Fusion Proteins, bcr-abl; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, SCID; Protein Kinase Inhibitors; Pyrimidines; Xenograft Model Antitumor Assays

2008